peanut allergen oral immunotherapy

Peanut allergen oral immunotherapy (OIT) is an investigational, non-commercial biological intervention developed by researchers at Charité Universitätsmedizin Berlin. It involves the daily oral administration of gradually increasing doses of roasted peanut flour, typically delivered in a chocolate pudding vehicle, to children with IgE-mediated peanut allergies. The treatment aims to modulate the immune system to induce desensitization and clinical tolerance to peanut proteins, thereby reducing the risk of severe allergic reactions or anaphylactic shock upon accidental exposure. This specific program is investigator-initiated and uses research-grade ingredients rather than a branded pharmaceutical product.

Other names

Peanut OITroasted peanut flour